Isomorphic Labs Secures $2.1 Billion for AI Drug Discovery
Isomorphic Labs has completed a $2.1 billion fundraising round, marking a significant investment in the field of AI-driven drug discovery.
4 stories found
Isomorphic Labs has completed a $2.1 billion fundraising round, marking a significant investment in the field of AI-driven drug discovery.
Isomorphic Labs, a Google-backed artificial intelligence drug discovery company, is reportedly looking to raise more than $2 billion in new funding. This significant investment would fuel its research and development efforts.
Isomorphic Labs, a DeepMind spinout backed by Google, has successfully raised $2.1 billion to advance its efforts in AI-driven drug discovery. The substantial funding aims to scale its cutting-edge research in developing new medicines.
Isomorphic Labs, Google's AI drug discovery subsidiary, is reportedly looking to raise more than $2 billion in a new funding round.